Invention Grant
- Patent Title: Modified exedins and uses thereof
- Patent Title (中): 改良的exedins及其用途
-
Application No.: US11813917Application Date: 2006-01-10
-
Publication No.: US08097586B2Publication Date: 2012-01-17
- Inventor: Aifeng Lv , Changan Sun , Yali Wang
- Applicant: Aifeng Lv , Changan Sun , Yali Wang
- Applicant Address: CN Jiangsu
- Assignee: Wuxi Grandchamp Pharmaceutical Technology Co., Ltd.
- Current Assignee: Wuxi Grandchamp Pharmaceutical Technology Co., Ltd.
- Current Assignee Address: CN Jiangsu
- Agency: Norris McLaughlin & Marcus, P.A.
- Priority: CN200510038102 20050114
- International Application: PCT/CN2006/000029 WO 20060110
- International Announcement: WO2006/074600 WO 20060720
- Main IPC: A61K38/00
- IPC: A61K38/00 ; A23J1/00
Abstract:
Novel exendins with modifications at one or more of following positions: 2, 14, 27 or 28 and polyethylene glycol derivatives thereof are provided. These compounds are useful in treating type 2 diabetes as GLP-1 receptor agonists.
Public/Granted literature
- US20100009904A1 Modified Exedins and Uses Thereof Public/Granted day:2010-01-14
Information query
IPC分类:
